\nHenry Ford Health selected as one of only four U.S. academic health systems in Bayer\u2019s strategic research network<\/p>
DETROIT--(BUSINESS WIRE)--Bayer, a global life sciences company, and Henry Ford Health today announced a strategic partnership to expand clinical trial opportunities for patients. The work brings together Bayer\u2019s global drug development expertise with Henry Ford Health\u2019s comprehensive clinical research program and its deep connection to the communities it serves.<\/p>
\n\u201cClinical trials are often the first opportunity patients have to access cutting-edge treatments,\u201d said Dr. David Lanfear, Chief Scientific Officer for Henry Ford Health. \u201cThrough this collaboration, we aim to make clinical research more accessible, reduce barriers to participation, accelerate the development of new treatments and ensure that more patients have the opportunity to benefit from medical innovation.\u201d<\/p>
\nInitial efforts will focus on several key areas that align with Bayer\u2019s growing pipeline and product offerings:<\/p>
\nTogether, the organizations will collaboratively work across the full clinical trial process, using data and technology to design smarter trials. Patients will be able to access novel treatments sooner by reducing barriers to participation.<\/p>
\n\u201cBayer is consistently exploring new avenues that can help more patients with diseases or health conditions that impact millions of people across the world,\u201d said Christoph Koenen, Head, Clinical Development & Operations for Bayer. \u201cWe share this commitment to patients and advancing drug discovery with likeminded institutions like Henry Ford Health that can help reduce barriers to accessing investigational or potential new treatments right in the very communities where patients are already receiving their care.\u201d<\/p>
\nThe partnership will add more areas of medicinal research as time goes on. Beyond clinical trials, the organizations plan to work together in areas such as:<\/p>
\nThe partnership reflects a shared commitment to advancing clinical research in ways that are faster, more inclusive, and more accessible for patients.<\/p>
\nHenry Ford Health is one of only four academic health systems in the U.S. selected to work with Bayer in this strategic research model, reflecting its clinical expertise, integrated care network, diverse patient population and strong track record in clinical research. In July, Bayer announced its first strategic alliance with the University of Colorado Anschutz<\/a>, UCHealth<\/a> and Children\u2019s Hospital Colorado<\/a> to advance drug development and clinical trials.<\/a><\/p> \n\u201cThis partnership builds on Henry Ford Health\u2019s longstanding leadership in clinical research and creates new opportunities to bring innovative studies to our patients,\u201d Lanfear said. \u201cBy combining our expertise with Bayer\u2019s global research capabilities, we can help advance treatments in areas that matter most while ensuring research reflects the needs of the diverse communities we serve.\u201d<\/p> \nAbout Bayer\n \nAbout Henry Ford Health\n \nElaine Colon\n Henry Ford Health selected as one of only four U.S. academic health systems in Bayer\u2019s strategic research networkDETROIT–(BUSINESS WIRE)–Bayer, a global life sciences company, and Henry Ford Health today announced a strategic partnership to expand c…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-38779","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/38779","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=38779"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/38779\/revisions"}],"predecessor-version":[{"id":38780,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/38779\/revisions\/38780"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=38779"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=38779"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=38779"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}